Altered metabolism of maternal micronutrients and omega 3 fatty acids epigenetically regulate matrix metalloproteinases in preterm pregnancy: A novel hypothesis

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 878-883

  Sundrani, Deepali P ^a   Chavan Gautam, Preeti M ^a   Mehendale, Savita S ^b   Joshi, Sadhana R ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COPPER; CYANOCOBALAMIN; DNA; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; LONG CHAIN FATTY ACID; MATRIX METALLOPROTEINASE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; S ADENOSYLMETHIONINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRACE ELEMENT; ZINC;

ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; COPPER DEFICIENCY; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; DNA METHYLATION; EPIGENETICS; FATTY ACID METABOLISM; FOLIC ACID DEFICIENCY; GENE EXPRESSION; GENETIC REGULATION; HIGH RISK PREGNANCY; HUMAN; HYPOTHESIS; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL NUTRITION; METABOLIC DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; RISK FACTOR; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; VITAMIN INTAKE; ZINC DEFICIENCY;

EPIGENESIS, GENETIC; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MATRIX METALLOPROTEINASES; MODELS, THEORETICAL; OBSTETRIC LABOR, PREMATURE; OXIDATIVE STRESS; PREGNANCY;

EID: 80053961376     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.001     Document Type: Article

References (130)

1. Saigal S., Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008, 371(9608):261-269. [PubMed: 18207020].
2. Stacy B., Daniel W., Lale S., et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull 31 World Health Organ 2010, 88:31-38. PubMed: 20428351.
3. Challis J.R.G., Matthews S.G., Gibb W., Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000, 21:514-550. [PubMed: 11041447].
4. Hertelendy F., Zakar T. Prostaglandins and the myometrium and cervix. Prostaglandins Leukot Essent Fatty Acids 2004, 70:207-222. [PubMed: 14683694].
5. Iams J.D., Romero R., Culhane J.F., Goldenberg R.L. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008, 371:164-175. [PubMed: 18191687].
6. Lindsay H.A. Multiple micronutrients in pregnancy and lactation: an overview. Am J Clin Nutr 2005, 81(5):1206S-1212S. [PubMed: 15883453].
7. Keen C.L., Clegg M.S., Hanna L.A., et al. The plausibility of micronutrient deficiencies being a significant contributing factor to the occurrence of pregnancy complications. J Nutr 2003, 133:1597S-1605S. [PubMed: 12730474].
8. Simpson J.L., Bailey L.B., Pietrzik K., Shane B., Holzgreve W. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I-Folate, Vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med 2010, 23(12):1323-1343. [PubMed: 20373888].
9. Stephen O., Caroline F. Consequences of poor maternal micronutrition before and during early pregnancy. Trans R Soc Trop Med Hyg 2008, 102(2):103-104. [PubMed: 10799405].
10. Scholl T.O., Johnson W.G. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000, 71(Suppl):1295S-1303S.
11. Timmermans S., Jaddoe V.W., Hofman A., Steegers-Theunissen R.P., Steegers E.A. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. Br J Nutr 2009, 102(5):777-785. [PubMed: 19327193].
12. Chiaffarino F., Ascone G.B., Bortolus R., Mastroia-Covo P., Ricci E., Cipriani S., et al. Effects of folic acid supplementation on pregnancy outcomes: a review of randomized clinical trials. Minerva Ginecol 2010, 62(4):293-301. [PubMed: 20827247].
13. Szostak-Wegierek D. Importance of proper nutrition before and during pregnancy. Med Wieku Rozwoj 2000;4(3 Suppl 1):77-88. [PubMed: 11381154].
14. Berry RJ, Bailey L, Mulinare J, Bower C, Folic Acid Working Group. Fortification of flour with folic acid. Food Nutr Bull 2010;31(1 Suppl):S22-35. [PubMed: 20629350].
15. Shaw G.M., Carmichael S.L., Nelson V., Selvin S., Schaffer D.M. Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public Health Rep 2004, 119(2):170-173. [PubMed: 15192904.
16. Czeizel A.E., Puhó E.H., Langmar Z., Acs N., Bánhidy F. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur J Obstet Gynecol Reprod Biol 2010, 148(2):135-140. [PubMed: 20618724].
17. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morb Mortal Wkly Rep 2010;59(31):980-4. [PubMed: 20618724].
18. Amarin ZO, Obeidat AZ. Effect of folic acid fortification on the incidence of neural tube defects. Paediatr Perinat Epidemiol 2010;24(4):349-51. [PubMed: 21630426].
19. Orioli IM, Lima do Nascimento R, López-Camelo JS, Castilla EE. Effects of folic acid fortification on spina bifida prevalence in Brazil. Birth Defects Res A Clin Mol Teratol 2011. doi: 10.1002/bdra.20830 [PubMed: 21630426].
20. Blencowe H., Cousens S., Modell B., Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39(Suppl 1):i110-21. [PubMed: 20348114].
21. Rader J.I. Folic acid fortification, folate status and plasma homocysteine. J Nutr 2002, 132(8 Suppl):2466S-2470S. [PubMed: 12163713].
22. Green R., Miller J.W. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 2005, 43(10):1048-1051. [PubMed: 16197296].
23. Lindblad B., Zaman S., Malik A., Martin H., Ekström A.M., Amu S., et al. Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynecol Scand 2005, 84(11):1055-1061. [PubMed: 16232172].
24. Milman N., Byg K.E., Bergholt T., Eriksen L., Hvas A.M. Cobalamin status during normal pregnancy and postpartum: a longitudinal study comprising 406 Danish women. Eur J Haematol 2006, 76(6):521-525. [PubMed: 16548919].
25. Katre P., Bhat D., Lubree H., et al. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status. Asia Pac J Clin Nutr 2010, 19(3):335-343. [PubMed: 20805077].
26. Cho E., Holmes M., Hankinson S.E., Willett W.C. Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women. Cancer Epidemiol Biomarkers Prev 2007, 16(12):2787-2790. [PubMed: 18086790].
27. Kalhan SC. Metabolism of methionine in vivo: impact of pregnancy, protein restriction, and fatty liver disease. Nestle Nutr Workshop Ser Pediatr Program 2009;63:121-31; discussion 131-33, 259-68. [PubMed: 19346772].
28. Dunlevy L.P., Burren K.A., Chitty L.S., Copp A.J., Greene N.D. Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett 2006, 580(11):2803-2807. [PubMed: 16674949].
29. Miller J.W., Nadeau M.R., Smith J., Smith D., Selhub J. Folate-deficiencyinduced homocysteinaemia in rats: disruption of S-adenosylmethionine=s co-ordinate regulation of homocysteine metabolism. Biochem J 1994, 298:415-419. [PubMed: 8135750].
30. Ashworth C.J., Antipatis C. Micronutrient programming of development throughout gestation. Reproduction 2000, 122:527-535. [PubMed: 11570959].
31. Scholl T.O., Hediger M.L., Schall J.I., Fischer R.L., Khoo C.S. Low zinc intake during pregnancy: its association with preterm and very preterm delivery. Am J Epidemiol 1993, 137(10):1115-1124. [PubMed: 11570959].
32. Garg H.K., Singhal K.C., Arshad Z. A study of the effect of oral zinc supplementation during pregnancy on pregnancy outcome. Indian J Physiol Pharmacol 1993, 37:276-284. [PubMed: 8112803].
33. Simmer K., Lort-Phillips L., James C., Thompson R.P. A double-blind trial of zinc supplementation in pregnancy. Eur J Clin Nutr 1991, 45:139-144. [PubMed: 2065637].
34. Cherry F.F., Sandstead H.H., Rojas P., Johnson L.K., Batson K.H., Wang X.B. Adolescent pregnancy: associations among body weight, zinc nutriture, and pregnancy outcome. Am J Clin Nutr 1989, 50:945-954. [PubMed: 2816802].
35. Goldenberg R.L., Tamura T., Neggers Y., et al. The effect of zinc supplementation on pregnancy outcome. JAMA 1995, 274:463-468. [PubMed: 7629954].
36. Osendarp S.J., van Raaij J.M., Darmstadt G.L., Baqui A.H., Hautvast J.G., Fuchs G.J. Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomised placebo controlled trial. Lancet 2001, 357:1080-1085. [PubMed: 11297959].
37. Hardman B., Luff S., Ackland M.L. Differential intracellular localisation of the Menkes and Wilson copper transporting ATPases in the third trimester human placenta. Placenta 2011, 32(1):79-85. [PubMed: 21115196].
38. Gambling L, Andersen HS, McArdle HJ. Iron and copper, and their interactions 631 during development. Biochem Soc Trans 2008;36(Pt6):1258-61. [PubMed: 19021536].
39. Pathak P., Kapil U. Role of trace elements zinc, copper and magnesium during pregnancy and its outcome. Indian J Pediatr 2004, 71(11):1003-1005. [PubMed: 15572821].
40. Olivares M., Uauy R. Copper as an essential nutrient. Am J Clin Nutr 1996, 63(5):791S-796S. [PubMed: 8615366].
41. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr 1996, 63(5):797S-811S. [PubMed: 8615367].
42. Prohaska J.R. Long-term functional consequences of malnutrition during brain development: copper. Nutr 2000, 16:502-504. [PubMed: 10906536].
43. Prohaska J.R., Gybina A.A. Rat brain iron concentration is lower following perinatal copper deficiency. J Neurochem 2005, 93:698-705. [PubMed:15836628].
44. Gambling L., McArdle H.J. Iron, copper and fetal development. Proc Nutr Soc 2004, 63(4):553-562. [PubMed: 15831127].
45. Pita M.L., Delgado M.J. Folate administration increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost 2000, 84(3):420-423. [PubMed: 11019965].
46. Koletzko B., Cetin I., Brenna J.T., et al. Dietary fat intakes for pregnant and lactating women. Br J Nutr 2007, 98(5):873-877. [PubMed 17688705].
47. Makrides M, Smithers LG, Gibson RA. Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth. Nestle Nutr Workshop Ser Pediatr Program 2010;65:123-33; discussion 133-36. [PubMed: 20139678].
48. Joshi S., Rao S., Girigosavi S., Daware M., Kale A., Hegde M. Differential effects of fish oil and folate supplementation during pregnancy in rats on cognitive performance and serum glucose level in their offspring. Nutrition 2004, 20(5):465-472. [PubMed: 15105035].
49. Mehendale S., Kilari A., Dangat K., Taralekar V., Mahadik S., Joshi S. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynaecol Obstet 2008, 100(3):234-238. [PubMed: 17977540].
50. Kilari A.S., Mehendale S.S., Dangat K.D., et al. Long chain polyunsaturated fatty acids in mothers and term babies. J Perinat Med 2009, 37(5):513-518. [PubMed: 19492914].
51. Kilari A, Mehendale S, Dangat K, Pisal H, Joshi S. Associations of long-chain polyunsaturated fatty acid concentrations with birth outcome in term Indian mothers and their neonates. Am J Hum Biol 2010. [PubMed: 21170964].
52. Kilari A.S., Mehendale S.S., Dangat K.D., et al. Long chain polyunsaturated fatty acids in mothers of preterm babies. J Perinat Med 2010, 38(6):659-664. [PubMed: 20807011].
53. Dangat K.D., Mehendale S.S., Yadav H.R., et al. Long-chain polyunsaturated fatty acid composition of breast milk in pre-eclamptic mothers. Neonatology 2010, 97:190-194. [PubMed: 19864925].
54. Kulkarni A.V., Mehendale S.S., Yadav H.R., Joshi S.R. Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt-1 in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2011, 84(1-2):51-55. [PubMed: 20956072].
55. Refsum H., Yajnik C.S., Gadkari M., et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001, 74:233-241. [PubMed: 11470726].
56. Kulkarni A., Mehendale S., Pisal H., et al. Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. Clin Nutr 2011, 30(1):60-64. [PubMed: 20719412].
57. Ronnenberg A.G., Goldman M.B., Chen D., et al. Preconception folate and vitamin B6 status and clinical spontaneous abortion in Chinese women. Obstet Gynecol 2002, 100(1):107-113. [PubMed: 12100811].
58. Ferguson S.E., Smith G.N., Walker M.C. Maternal plasma homocysteine levels in women with preterm premature rupture of membranes. Med Hypotheses 2001, 56(1):85-90. [PubMed: 11133260].
59. McNulty H., Cuskelly G.J., Ward M. Response of red blood cell folate to intervention: implications for folate recommendations for the prevention of neural tube defects. Am J Clin Nutr 2000, 71(5 Suppl):1308S-1311S. [PubMed: 10799407].
60. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Eng J Med 1998, 338:1042-1050. [PubMed: 9535670].
61. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986, 77:1370-1376. [PubMed: 3514679].
62. Var A., Yildirim Y., Onur E., et al. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 2003, 56(4):221-224. [PubMed: 14614253].
63. Joshi S.R., Mehendale S.S., Dangat K.D., Kilari A.S., Yadav H.R., Taralekar V.S. High maternal plasma antioxidant concentrations associated with preterm delivery. Ann Nutr Metab 2008, 53(3-4):276-282. [PubMed: 19141991].
64. Perkins A.V. Endogenous anti-oxidants in pregnancy and preeclampsia. Aust NZ J Obstet Gynaecol 2006, 46:77-83. [PubMed: 16638026].
65. Al-Gubory K.H., Fowler P.A., Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010, 42(10):1634-1650. [PubMed: 20601089].
66. Chappell L.C., Seed P.T., Briley A.L., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999, 354:810-816. [PubMed: 10485722].
67. Casanueva E., Ripoll C., Tolentino M., et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr 2005, 81(4):859-863. [PubMed: 15817864].
68. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008;(1):CD004227. [PubMed: 18254042].
69. Villar J., Purwar M., Merialdi M., et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG 2009, 116(6):780-788. [PubMed: 19432566].
70. Roberts J.M., Myatt L., Spong C.Y., et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010, 362(14):1282-1291. [PubMed: 20375405].
71. Hauth J.C., Clifton R.G., Roberts J.M., et al. Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial. Obstet Gynecol 2010, 116(3):653-658. [PubMed: 20733448].
72. Vadillo-Ortega F, Perichart-Perera O, Espino S, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011;342:d2901. doi: 10.1136/bmj.d2901. [PubMed: 21596735].
73. Xu H, Perez-Cuevas R, Xiong X, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010;202(3):239.e1-239.e10. [PubMed: 20207239].
74. Rahimi R., Nikfar S., Rezaie A., Abdollahi M. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens Pregnancy 2009, 28(4):417-434. [PubMed: 19843004].
75. Spinnato JA 2nd, Freire S, Pinto e Silva JL, et al. Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol 2008;199(4):433.e1-8. [PubMed: 18928997].
76. Jones R.L., Findlay J.K., Farnworth P.G., Robertson D.M., Wallace E., Salamonsen L.A. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006, 147(2):724-732. [PubMed: 16282351].
77. Curry T.E., Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003, 24(4):428-465. [PubMed: 12920150].
78. Naruse K., Lash G.E., Innes B.A., et al. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod 2009, 24(3):553-561. [PubMed: 19088110].
79. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-2154. [PubMed: 8674412].
80. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2(3):161-174. [PubMed: 1850705].
81. Cockle J.V., Gopichandran N., Walker J.J., Levene M.I., Orsi N.M. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod Sci 2007, 14(7):629-645. [PubMed: 18000225].
82. Zitka O., Kukacka J., Krizkova S., et al. Matrix metalloproteinases. Curr Med Chem 2010, 17(31):3751-3768. [PubMed: 20846107].
83. Patterson M.L., Atkinson S.J., Knäuper V., Murphy G. Specific collagenolysis by gelatinase A MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 2001, 503:158-162. [PubMed: 11513874].
84. Lansdown A.B., Mirastschijski U., Stubbs N., Scanlon E., Agren M.S. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 2007, 15(1):2-16. [PubMed: 17244314].
85. Binnebösel M., Grommes J., Koenen B., et al. Zinc deficiency impairs wound healing of colon anastomosis in rats. Int J Colorectal Dis 2010, 25(2):251-257. [PubMed: 19859719].
86. Song Y., Leonard S.W., Traber M.G., Ho E. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and DNA repair in rats. J Nutr 2009, 139(9):1626-1631. [PubMed: 19625698].
87. Guo H., Lee J.D., Uzui H., et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J 2006, 70(1):141-146. [PubMed: 16377938].
88. Tyagi N., Gillespie W., Vacek J.C., Sen U., Tyagi S.C., Lominadze D. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol 2009, 220(1):257-266. [PubMed: 19308943].
89. Ke X.D., Foucault-Bertaud A., Genovesio C., Dignat-George F., Lamy E., Charpiot P. Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol Cell Biochem 2010, 335(1-2):203-210.
90. Kundu S., Tyagi N., Sen U., Tyagi S.C. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Mol Cell Biochem 2009, 332(1-2):215-224.
91. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 2002;6(1):39-42. [PubMed: 11813080].
92. Roy S, Kale A, Dangat K, Sable P, Kulkarni A, Joshi S. Maternal micronutrients (folic acid and vitamin B12) and omega 3 fatty acids: Implications for neurodevelopmental risk in the rat offspring. Brain Dev 2011. [PubMed: 19590937].
93. Kale A., Naphade N., Sapkale S., et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res 2010, 175(1-2):47-53. [PubMed: 21300490].
94. Kulkarni A., Dangat K., Kale A., Sable P., Chavan-Gautam P., Joshi S. Effects of Altered Maternal Folic Acid, Vitamin B12 and Docosahexaenoic Acid on Placental Global DNA Methylation Patterns in Wistar Rats. PLoS ONE 2011, 6(3):e17706. [PubMed: 19969375].
95. Chavan-Gautam P., Sundrani D., Pisal H., Nimbargi V., Mehendale S., Joshi S. Gestation-dependent changes in human placental global DNA methylation levels. Mol Reprod Dev 2011, 78(3):150. [PubMed: 21423696].
96. Llorente E., Brito M.L., Machado P., Gonzalez M.C. Effect of prenatal stress on the response to acute and chronic stress and on immune parameters in the offspring. J Physiol Biochem 2002, 58:143-149. [PubMed: 21425205].
97. Weinstock M. The potential influence of maternal stress hormones on the development and mental health of the offspring. Brain Behav Immun 2005, 19:296-308. [PubMed: 12603008].
98. Lebenthal E., Bier D.M. Novel concepts in the developmental origins of adult health and disease. J Nutr 2007, 137:1073-1075. [PubMed: 15944068].
99. Leitner Y., Fattal-Valevski A., Geva R., et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J Child Neurol 2007, 22(5):580-587. [PubMed: 17374680].
100. Ozdemir O.M., Ergin H., Sahiner T. Electrophysiological assessment of the brain functions in term SGA infants. Brain Res 2009, 1270:33-38. [PubMed: 17690065].
101. Procianoy R.S., Koch M.S., Silveira R.C. Neurodevelopmental outcome of appropriate and small for gestational age very low birth weight infants. J Child Neurol 2009, 24(7):788-794. [PubMed: 19303865].
102. Baschat A.A., Viscardi R.M., Hussey-Gardner B., Hashmi N., Harman C. Infant neurodevelopment following fetal growth restriction: relationship with antepartum surveillance parameters. Ultrasound Obstet Gynecol 2009, 33:44-50. [PubMed: 19289693].
103. Latal B. Prediction of neurodevelopmental outcome after preterm birth. Pediatr Neurol 2009, 40(6):413-419. [PubMed: 19072744].
104. Shum D., Neulinger K., O'Callaghan M., Mohay H. Attentional problems in children born very preterm or with extremely low birth weight at 7-9 years. Arch Clin Neuropsychol 2008, 23:103-112. [PubMed: 19433273].
105. Delobel-Ayoub M., Arnaud C., White-Koning M., et al. Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics 2009, 123:1485-1492.
106. Doyle L.W., Anderson P.J. Adult outcome of extremely preterm infants. Pediatrics 2010, 126:342-351. [PubMed: 19482758].
107. Hanson MA, Gluckman PD. Developmental origins of health and disease: new insights. Basic Clin Pharmacol 2008;102:90-93. [PubMed: 20679313].
108. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359:61-73. [PubMed: 18596274].
109. Shah B., Mathur P. Surveillance of cardiovascular disease risk factors in India: The need & scope. Indian J Med Res 2010, 132(5):634-642. [PubMed: 21150017].
110. Wjst M., Popescu M., Trepka M.J., Heinrich J., Wichmann H.E. Pulmonary function in children with initial low birth weight. Pediatr Allergy Immunol 1998, 9(2):80-90. [PubMed: 9677603].
111. Godfrey K.M., Barker D.J.P. Fetal nutrition and adult disease. Am J Clin Nutr 2000, 71(suppl):1344S-1352S. [PubMed: 10799412].
112. Mi J., Law C., Zhang K.L., Osmond C., Stein C., Barker D. Effects of infant birth weight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 2000, 132:253-260. [PubMed: 10681279].
113. Law C.M., Egger P., Dada O., et al. Body size at birth and blood pressure among children in developing countries. Int J Epidemiol 2001, 30:52-57. [PubMed: 11171856].
114. Selley M.L. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 2007, 28:1834-1839. [PubMed: 16996649].
115. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004, 20:63-68. [PubMed: 14698016].
116. Yajnik C.S., Deshmukh U.S. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord 2008, 9:203-211. [PubMed: 18661241].
117. Fortunato S.J., Menon R., Lombardi S.J. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999, 27(5):362-368. [PubMed: 10642956].
118. Athayde N., Romero R., Gomez R., et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med 1999, 8(5):213-219. [PubMed: 10475503].
119. Maymon E., Romero R., Pacora P., et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 2001, 29(4):308-316. [PubMed: 11565199].
120. Park K.H., Chaiworapongsa T., Kim Y.M., et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 2003, 31(1):12-22. [PubMed: 11565199].
121. Demir-Weusten A.Y., Seval Y., Kaufmann P., Demir R., Yucel G., Huppertz B. Matrix metalloproteinases -2, -3 and -9 in human term placenta. Acta Histochem 2007, 109(5):403-412. [PubMed: 17559909].
122. Solakivi T., Kunnas T., Kärkkäinen S., Jaakkola O., Nikkari S.T. Arachidonic acid increases matrix metalloproteinase 9 secretion and expression in human monocytic MonoMac 6 cells. Lipids Health Dis 2009, 8:11. [PubMed: 19331685].
123. Zainal Z., Longman A.J., Hurst S., et al. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage 2009, 17(7):896-905. [PubMed: 19217322].
124. Zeydanli E.N., Turan B. Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta. Can J Physiol Pharmacol 2009, 87(12):1063-1073. [PubMed: 20029543].
125. Donkena K.V., Young C.Y., Tindall D.J. Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010, 2010:302051. [PubMed: 20671914].
126. Wang H., Ogawa M., Wood J.R., et al. Genetic and epigenetic mechanisms combine to control MMP1 expression and its association with preterm premature rupture of membranes. Hum Mol Genet 2008, 17(8):1087-1096. [PubMed: 18178580].
127. Bruno M.A., Mufson E.J., Wuu J., Cuello A.C. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 2009, 68(12):1309-1318. [PubMed: 19915485].
128. Horstmann S., Budig L., Gardner H., et al. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int Psychogeriatr 2010, 22(6):966-972. [PubMed: 20561382].
129. Wang X, Li KF, Adams E, Van Schepdael A. Matrix metalloproteinase inhibitors: a review on bioanalytical methods, pharmacokinetics and metabolism. Curr Drug Metab 2011 [PubMed: 21395524].
130. Hansson J., Vasan R.S., Ärnlöv J., et al. Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS ONE 2011, 6(1):e16185. [PubMed: 21283828].